Developer docs
API playgroundTry for free, no card

Search company profiles

Abbott Ventures

Full company profile

uuid003v5ci

Namestring
Abbott Ventures
Legal namestring
Abbott Laboratories
Websiteurl
abbott.com
Company typeenum
Public
Founded yearint
1888
Short descriptiontext

Abbott Laboratories is a diversified global healthcare company that develops medical devices, diagnostics, nutrition, and pharmaceuticals across cardiovascular, diabetes, oncology, and consumer health. It serves hospitals, providers, and consumers in more than 35 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersCarthage, United States
HQ citystring
Carthage
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, medical technology investments, healthcare venture capital, medtech startup funding, strategic health investments
Industry2 codes
PRIMARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code1 code
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital Investment
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Devices
TypeHardware Sales
Description

Cardiovascular devices including heart valves, LVADs, pacemakers, implantable cardiac monitors, and structural heart devices. This segment performed well in Q3 2025 with sales surpassing forecasts, offsetting weakness in other segments.

investors.com
2Diagnostics
TypeHardware Sales
Description

Diagnostic testing products including COVID-19 testing which has seen declining demand. Weakness in diagnostics impacted overall performance in Q3 2025.

finance.yahoo.com
3Nutrition
TypeHardware Sales
Description

Nutritional products including Ensure, Similac, Pedialyte, and Pedialyte Sport. This segment experienced weakness alongside diagnostics in Q3 2025.

finance.yahoo.com
4Established Pharmaceuticals
TypeHardware Sales
Description

Branded and generic pharmaceutical products across multiple markets.

investors.com
5Cancer Testing (via Exact Sciences)
TypeHardware Sales
Description

Following the acquisition of Exact Sciences, Abbott now offers Cologuard, Cologuard Plus, Cancerguard, Oncotype DX, and Oncodetect cancer screening and diagnostic tests.

abbott.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Others
Pricing details2 tiers
1Pedialyte Sport - Electrolyte drink with 3x electrolytes and 1/4 the sugar of leading sports drinks
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Pedialyte Sport has 1380 mg sodium and no more than 14g sugars per liter compared to leading sports drink at ~460 mg sodium and ~58g sugars per liter

abbott.com
2Ensure Max Protein nutrition shakes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Contains 30 grams of high-quality protein to help maintain muscle and manage hunger

abbott.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 11 records shown
1FreeStyle Libre
Description

Continuous glucose monitoring (CGM) systems for people with diabetes

abbott.com
+10 more records
Core offering1 text field

Abbott Ventures is a corporate venture capital subsidiary of Abbott that makes equity investments in emerging medical technology companies. It deploys strategic capital into early- and growth-stage medtech businesses, leveraging the parent organization's healthcare industry presence and product portfolio spanning medical devices, diagnostics, nutrition, and pharmaceuticals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Abbott has increased dividends for 53 consecutive years, making it an attractive dividend stock for passive income investors
+3 more records
Product overview1 text field

Abbott is a global healthcare company offering a diversified portfolio of medical devices, diagnostics, nutrition products, and pharmaceutical products organized across several business segments. The core product portfolio includes FreeStyle Libre continuous glucose monitoring systems for diabetes care, cardiovascular devices including HeartMate 3 LVAD, Amplatzer occluders, CardioMEMS HF system, AVEIR DR pacemaker, Masters Series mechanical heart valves, and TriClip G4 system for structural heart repair. Following the 2025 acquisition of Exact Sciences, Abbott expanded into cancer diagnostics with Cologuard, Oncotype DX, Cancerguard, and Oncodetect tests. Abbott also offers consumer nutrition products including Ensure, Pedialyte, and Similac. The company sponsors the Abbott World Marathon Majors series and runs community programs like Abbott HeartMates. Abbott operates with approximately 122,000 employees and has been advancing life-changing healthcare technology since 1888.

Product and service1 record
1Venture Capital Investments in Emerging Medical Technology
CategoryVenture Capital
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Abbott acquired Exact Sciences in 2025, adding leading cancer testing products including Cologuard (colorectal cancer screening), Cancerguard (multi-cancer blood test), Oncotype DX (breast cancer recurrence test), and Oncodetect (circulating tumor DNA test) to Abbott's portfolio. The acquisition aims to advance earlier cancer detection and personalized treatment decisions for millions of people.

2Tedy Bruschi
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2024-04-20
Description

Three-time NFL pro league champion Tedy Bruschi serves as ambassador for Abbott HeartMates. Bruschi experienced a stroke caused by a hole in his heart in 2005 and received an Abbott Amplatzer device, enabling him to rejoin his team months later and be named the 2005 Comeback Player of the Year.

abbott.com
3Damar Hamlin
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2023-10-27
Description

NFL player Damar Hamlin serves as captain of the Abbott HeartMates program, a community for people with heart conditions and their loved ones to share stories and receive emotional support. Hamlin experienced a cardiac event during a game in January 2023 and made an inspiring comeback, embodying the program's message of resilience and community support.

abbott.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-18
Description

Abbott is the global health sciences and nutrition partner of Real Madrid FC since 2021. The partnership includes the Abbott-Real Madrid Innovation Lab inside Real Madrid's training facilities where Abbott scientists and Real Madrid's medical team work together to advance sports health, nutrition, and science. Real Madrid players use Abbott products like Ensure Max Protein and Pedialyte Sport.

5Real Madrid Foundation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-18
Description

Abbott is a global partner of the Real Madrid Foundation, working to combat global malnutrition through screening programs and nutrition education to help improve the well-being of children worldwide. The partnership delivered over 35,000 hours of nutrition education in 10 countries in 2023 and screened more than 1,700 students for malnutrition in six countries.

abbott.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Dexcom is a leading continuous glucose monitoring (CGM) company that competes with Abbott's FreeStyle Libre franchise and engages in adjacent strategic investments in metabolic health and diabetes technology. It is a relevant emerging peer given overlapping diabetes technology adjacency to Abbott Ventures' medical technology thesis.

TypeDirect peer
Description

Philips Health Technology Ventures is the corporate venture arm of Royal Philips, focused on medical devices, digital health, and diagnostics investments. It is a direct peer given comparable healthcare-major parent and similar medical technology and digital health investment focus.

TypeDirect peer
Description

Novartis Venture Fund is the corporate venture capital arm of Novartis, focused on early-stage life sciences, medical devices, and digital health investments. It is a direct peer given the comparable large-cap pharmaceutical/healthcare parent and similar sector-specialist CVC mandate.

TypeDirect peer
Description

Johnson & Johnson Innovation - JJDC is the dedicated corporate venture capital arm of Johnson & Johnson, making minority equity investments in early-stage healthcare and medical technology companies. It is the closest direct peer to Abbott Ventures given the comparable parent scale (large-cap healthcare major) and similar medical technology investment focus.

TypeDirect peer
Description

Boston Scientific's corporate venture program targets minority investments in early-stage medical device companies, particularly in cardiology and structural heart adjacencies. It is a direct peer to Abbott Ventures given its medical device major parent and overlapping cardiovascular investment focus.

TypeBroad incumbent
Description

Stryker is a major medical device incumbent that deploys strategic capital through M&A and minority investments in orthopedics, medical/surgical, and neurotechnology companies. It is comparable to Abbott Ventures as a medical-device-major strategic investor, though Stryker's strategic capital deployment is weighted toward larger M&A rather than early-stage venture.

7Becton Dickinson (BD) Ventures
TypeDirect peer
Description

BD Ventures is the corporate venture arm of Becton Dickinson, investing in medical technology, diagnostics, and life sciences companies. It is a direct peer given comparable medical device/diagnostics-major parent and similar emerging medical technology investment thesis.

TypeDirect peer
Description

Medtronic's corporate venture investing program targets emerging medical device, diagnostics, and digital health companies aligned with Medtronic's therapeutic areas. It is a direct peer to Abbott Ventures as both are medical-device-major CVCs with similar sector mandates and strategic-acquirer exit pathways.

TypeDirect peer
Description

GE Healthcare has invested through various strategic venture initiatives targeting emerging medical imaging, diagnostics, and digital health companies. It is a direct peer to Abbott Ventures as a healthcare-major CVC with overlapping medical technology investment themes.

TypeDirect peer
Description

Roche Venture Fund is the corporate venture arm of Roche, investing in early-stage diagnostics, medical devices, and digital health companies. It is a direct peer given comparable healthcare-major parent, similar sector focus, and equivalent strategic-investor value proposition to portfolio companies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Abbott Ventures

Venture Capital Investmentabbott.com

Abbott Laboratories is a diversified global healthcare company that develops medical devices, diagnostics, nutrition, and pharmaceuticals across cardiovascular, diabetes, oncology, and consumer health. It serves hospitals, providers, and consumers in more than 35 countries.

Abbott Ventures firmographics

Firmographics
Name
Abbott Ventures
Legal name
Abbott Laboratories
Website
https://abbott.com
Company type
Public
Founded year
1888
Operating status
Operating
Headcount range
10,001+ employees
Short description
Abbott Laboratories is a diversified global healthcare company that develops medical devices, diagnostics, nutrition, and pharmaceuticals across cardiovascular, diabetes, oncology, and consumer health. It serves hospitals, providers, and consumers in more than 35 countries.
Ownership category
akta.pro rank

Abbott Ventures industry classification

Industry
Product category
Venture Capital Investment
NAICS
All Other Financial Investment Activities (52399)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms
SECONDARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Venture capital investing
  • Medical technology investments
  • Healthcare venture capital
  • Medtech startup funding
  • Strategic health investments

Where Abbott Ventures is headquartered

Location

Headquarters

HQ city
Carthage
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Abbott Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others

Revenue model

  1. Medical Devices: Cardiovascular devices including heart valves, LVADs, pacemakers, implantable cardiac monitors, and structural heart devices. This segment performed well in Q3 2025 with sales surpassing forecasts, offsetting weakness in other segments.
  2. Diagnostics: Diagnostic testing products including COVID-19 testing which has seen declining demand. Weakness in diagnostics impacted overall performance in Q3 2025.
  3. Nutrition: Nutritional products including Ensure, Similac, Pedialyte, and Pedialyte Sport. This segment experienced weakness alongside diagnostics in Q3 2025.
  4. Established Pharmaceuticals: Branded and generic pharmaceutical products across multiple markets.
  5. Cancer Testing (via Exact Sciences): Following the acquisition of Exact Sciences, Abbott now offers Cologuard, Cologuard Plus, Cancerguard, Oncotype DX, and Oncodetect cancer screening and diagnostic tests.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPedialyte Sport - Electrolyte drink with 3x electrolytes and 1/4 the sugar of leading sports drinks
Unit PricingPay-as-you-goEnsure Max Protein nutrition shakes

Go-to-market motion3 records

Distribution channels6 records

Marketing channels9 records

Abbott Ventures product offering

Product offering

Core offering

Abbott Ventures is a corporate venture capital subsidiary of Abbott that makes equity investments in emerging medical technology companies. It deploys strategic capital into early- and growth-stage medtech businesses, leveraging the parent organization's healthcare industry presence and product portfolio spanning medical devices, diagnostics, nutrition, and pharmaceuticals.

Product overview

Abbott is a global healthcare company offering a diversified portfolio of medical devices, diagnostics, nutrition products, and pharmaceutical products organized across several business segments. The core product portfolio includes FreeStyle Libre continuous glucose monitoring systems for diabetes care, cardiovascular devices including HeartMate 3 LVAD, Amplatzer occluders, CardioMEMS HF system, AVEIR DR pacemaker, Masters Series mechanical heart valves, and TriClip G4 system for structural heart repair. Following the 2025 acquisition of Exact Sciences, Abbott expanded into cancer diagnostics with Cologuard, Oncotype DX, Cancerguard, and Oncodetect tests. Abbott also offers consumer nutrition products including Ensure, Pedialyte, and Similac. The company sponsors the Abbott World Marathon Majors series and runs community programs like Abbott HeartMates. Abbott operates with approximately 122,000 employees and has been advancing life-changing healthcare technology since 1888.

Differentiator

Problem solved

Functional benefit

Brands

  • FreeStyle Libre: Continuous glucose monitoring (CGM) systems for people with diabetes
  • Lingo
  • Ensure
  • Similac
  • Pedialyte
  • HeartMate
  • Exact Sciences
  • Amplatzer
  • CardioMEMS
  • Aveir
  • i-STAT

Products and services

  • Venture Capital Investments in Emerging Medical Technology

Quantifiable outcome

  • Abbott has increased dividends for 53 consecutive years, making it an attractive dividend stock for passive income investors
  • +3 more outcomes

Companies that use Abbott Ventures

Customer profile

Named customers9 records

Segments6 records

Ideal customer profiles1 record

Abbott Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature11 records

Abbott Ventures partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Exact SciencescoreStrategic or Co-development Partner · 1 January 2025Abbott acquired Exact Sciences in 2025, adding leading cancer testing products including Cologuard (colorectal cancer screening), Cancerguard (multi-cancer blood test), Oncotype DX (breast cancer recurrence test), and Oncodetect (circulating tumor DNA test) to Abbott's portfolio. The acquisition aims to advance earlier cancer detection and personalized treatment decisions for millions of people.
  • Tedy BruschicoreGTM or Marketing Partner · 20 April 2024Three-time NFL pro league champion Tedy Bruschi serves as ambassador for Abbott HeartMates. Bruschi experienced a stroke caused by a hole in his heart in 2005 and received an Abbott Amplatzer device, enabling him to rejoin his team months later and be named the 2005 Comeback Player of the Year.
  • Damar HamlincoreGTM or Marketing Partner · 27 October 2023NFL player Damar Hamlin serves as captain of the Abbott HeartMates program, a community for people with heart conditions and their loved ones to share stories and receive emotional support. Hamlin experienced a cardiac event during a game in January 2023 and made an inspiring comeback, embodying the program's message of resilience and community support.
  • Real Madrid Football ClubcoreStrategic or Co-development Partner · 18 October 2021Abbott is the global health sciences and nutrition partner of Real Madrid FC since 2021. The partnership includes the Abbott-Real Madrid Innovation Lab inside Real Madrid's training facilities where Abbott scientists and Real Madrid's medical team work together to advance sports health, nutrition, and science. Real Madrid players use Abbott products like Ensure Max Protein and Pedialyte Sport.
  • Real Madrid FoundationcoreStrategic or Co-development Partner · 18 October 2021Abbott is a global partner of the Real Madrid Foundation, working to combat global malnutrition through screening programs and nutrition education to help improve the well-being of children worldwide. The partnership delivered over 35,000 hours of nutrition education in 10 countries in 2023 and screened more than 1,700 students for malnutrition in six countries.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Abbott Ventures competitors and assessment

Company assessment

Emerging players

  • Dexcom Ventures: Dexcom is a leading continuous glucose monitoring (CGM) company that competes with Abbott's FreeStyle Libre franchise and engages in adjacent strategic investments in metabolic health and diabetes technology. It is a relevant emerging peer given overlapping diabetes technology adjacency to Abbott Ventures' medical technology thesis.

Direct peers

  • Philips Health Technology Ventures: Philips Health Technology Ventures is the corporate venture arm of Royal Philips, focused on medical devices, digital health, and diagnostics investments. It is a direct peer given comparable healthcare-major parent and similar medical technology and digital health investment focus.
  • Novartis Venture Fund: Novartis Venture Fund is the corporate venture capital arm of Novartis, focused on early-stage life sciences, medical devices, and digital health investments. It is a direct peer given the comparable large-cap pharmaceutical/healthcare parent and similar sector-specialist CVC mandate.
  • Johnson & Johnson Innovation (JJDC): Johnson & Johnson Innovation - JJDC is the dedicated corporate venture capital arm of Johnson & Johnson, making minority equity investments in early-stage healthcare and medical technology companies. It is the closest direct peer to Abbott Ventures given the comparable parent scale (large-cap healthcare major) and similar medical technology investment focus.
  • Boston Scientific Ventures: Boston Scientific's corporate venture program targets minority investments in early-stage medical device companies, particularly in cardiology and structural heart adjacencies. It is a direct peer to Abbott Ventures given its medical device major parent and overlapping cardiovascular investment focus.
  • Becton Dickinson (BD) Ventures: BD Ventures is the corporate venture arm of Becton Dickinson, investing in medical technology, diagnostics, and life sciences companies. It is a direct peer given comparable medical device/diagnostics-major parent and similar emerging medical technology investment thesis.
  • Medtronic Ventures: Medtronic's corporate venture investing program targets emerging medical device, diagnostics, and digital health companies aligned with Medtronic's therapeutic areas. It is a direct peer to Abbott Ventures as both are medical-device-major CVCs with similar sector mandates and strategic-acquirer exit pathways.
  • GE Healthcare Ventures: GE Healthcare has invested through various strategic venture initiatives targeting emerging medical imaging, diagnostics, and digital health companies. It is a direct peer to Abbott Ventures as a healthcare-major CVC with overlapping medical technology investment themes.
  • Roche Venture Fund: Roche Venture Fund is the corporate venture arm of Roche, investing in early-stage diagnostics, medical devices, and digital health companies. It is a direct peer given comparable healthcare-major parent, similar sector focus, and equivalent strategic-investor value proposition to portfolio companies.

Broad incumbents

  • Stryker (Corporate Development / Investments): Stryker is a major medical device incumbent that deploys strategic capital through M&A and minority investments in orthopedics, medical/surgical, and neurotechnology companies. It is comparable to Abbott Ventures as a medical-device-major strategic investor, though Stryker's strategic capital deployment is weighted toward larger M&A rather than early-stage venture.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Abbott Ventures social profiles

Digital presence

Abbott Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Abbott Ventures leadership team

Management profile

Number of profiles

Profiles2 records

Abbott Ventures subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Abbott Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Abbott Ventures M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbott Ventures

What does Abbott Ventures do?

Abbott Ventures is a corporate venture capital subsidiary of Abbott that makes equity investments in emerging medical technology companies. It deploys strategic capital into early- and growth-stage medtech businesses, leveraging the parent organization's healthcare industry presence and product portfolio spanning medical devices, diagnostics, nutrition, and pharmaceuticals.

Is Abbott Ventures a public or private company?

Abbott Ventures is a public company. It is classified as corporate owned and is currently operating.

When was Abbott Ventures founded?

Abbott Ventures was founded in 1888. It employs 10,001+ people.

Where is Abbott Ventures based?

Abbott Ventures is headquartered in Carthage, United States, in the North America region.

How does Abbott Ventures make money?

Five revenue lines are on record. Medical Devices are the primary driver. The others are diagnostics, nutrition, established Pharmaceuticals and cancer Testing (via Exact Sciences).

Who are Abbott Ventures's main competitors?

Dexcom Ventures is listed as an emerging player. Direct peers are Philips Health Technology Ventures, Novartis Venture Fund, Johnson & Johnson Innovation (JJDC), Boston Scientific Ventures, Becton Dickinson (BD) Ventures, Medtronic Ventures, GE Healthcare Ventures and Roche Venture Fund. Stryker (Corporate Development / Investments) is listed as a broad incumbent.

Does Abbott Ventures have an API?

No public API is recorded for Abbott Ventures.

What industry is Abbott Ventures in?

Abbott Ventures's product category is Venture Capital Investment. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms, with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals